Table 2.
Variable | Patient-reported TO | p-value | Clinically defined TO | p-value |
---|---|---|---|---|
Demographics | ||||
Age, years, n (%) | ||||
<65 | 43 (84) | 0.54 | 30 (59) | 1.00 |
≥65 | 25 (89) | 17 (61) | ||
Gender, n (%) | ||||
Male | 29 (85) | 0.86 | 19 (55) | 0.57 |
Female | 39 (87) | 28 (62) | ||
Race, n (%) | ||||
White | 63 (86) | 0.84 | 45 (62) | 0.22 |
Non-White | 5 (83) | 2 (33) | ||
Patient and operative characteristics | ||||
BMI, n (%) | ||||
Normal | 21 (91) | 0.67 | 14 (61) | 0.96 |
Obese | 19 (83) | 14 (61) | ||
Overweight | 28 (85) | 19 (58) | ||
ASA class | ||||
2 | 10 (91) | 0.73 | 6 (55) | 0.90 |
3 | 56 (85) | 40 (61) | ||
4 | 2 (100) | 1 (50) | ||
Albumin, g/dl, n (%) | ||||
<3.5 | 17 (81) | 0.43 | 11 (52) | 0.44 |
≥3.5 | 51 (88) | 36 (62) | ||
Cancer diagnosis, n (%) | 59 (86) | 0.70 | 40 (58) | 0.47 |
Neoadjuvant therapy, n (%) | 22 (85) | 0.79 | 14 (54) | 0.47 |
Type of surgery, n (%) | ||||
Gastrointestinal | 32 (80) | 20 (50) | ||
Liver | 14 (100) | 0.28 | 13 (93) | 0.04 |
Pancreas | 20 (87) | 13 (57) | ||
Other | 2 (100) | 1 (50) | ||
Operative approach, n (%) | ||||
Open | 39 (93) | 22 (47) | ||
Robotic | 23 (96) | 0.13 | 19 (79) | 0.01 |
Laparoscopic | 3 (60) | 5 (100) | ||
Conversion to open | 3 (100) | 1 (33) | ||
Postoperative characteristics | ||||
Drain on discharge, n (%) | 6 (86) | 0.98 | 3 (43) | 0.35 |
Perioperative transfusion, n (%) | 3 (50) | 0.03 | - | - |
Postoperative complications, n (%) | 21 (78) | 0.12 | - | - |
Additional procedures, n (%) | 7 (78) | 0.44 | - | - |
Reoperation, n (%) | 1 (50) | 0.26 | - | - |
Length of stay >10 days, n (%) | 6 (75) | 0.34 | - | - |
Discharge to home, n (%) | 0 (0) | 0.14 | - | - |
Readmission ≤90 days, n (%) | 10 (59) | <0.01 | - | - |
ASA, American Society of Anesthesiologists; g/dl, grams/deciliter; TO, textbook outcome